Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia. | Front Immunol | 2022 | 36605213 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma. | Front Oncol | 2022 | 36591519 | PubTator, text mining | PubMed |
| Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU). | Front Immunol | 2022 | 36591282 | PubTator, text mining | PubMed |
| mRNA vaccines for cancer immunotherapy. | Front Immunol | 2022 | 36591226 | PubTator, text mining | PubMed |
| Research advances and challenges in tissue-derived extracellular vesicles. | Front Mol Biosci | 2022 | 36589228 | PubTator, text mining | PubMed |
| A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma. | Anal Cell Pathol (Amst) | 2022 | 36588797 | PubTator, text mining | PubMed |
| Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma. | Front Pharmacol | 2022 | 36588677 | PubTator, text mining | PubMed |
| A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. | Cell Biosci | 2022 | 36581992 | PubTator, text mining | PubMed |
| Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction. | Front Cell Dev Biol | 2022 | 36578789 | PubTator, text mining | PubMed |
| Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance. | Front Immunol | 2022 | 36569859 | PubTator, text mining | PubMed |
| Up-Regulation of SH3TC2 Induced by YTHDF1 Predicts Poor Outcome and Facilitates Cell-Cycle Progress in Colorectal Cancer. | J Oncol | 2022 | 36568637 | PubTator, text mining | PubMed |
| Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants. | Sci Adv | 2022 | 36563159 | PubTator, text mining | PubMed |
| Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer. | Oxid Med Cell Longev | 2022 | 36561981 | PubTator, text mining | PubMed |
| Age-dependent nasal immune responses in non-hospitalized bronchiolitis children. | Front Immunol | 2022 | 36561744 | PubTator, text mining | PubMed |
| iPSC-Derived Macrophages: The Differentiation Protocol Affects Cell Immune Characteristics and Differentiation Trajectories. | Int J Mol Sci | 2022 | 36555728 | PubTator, text mining | PubMed |
| The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands. | Int J Mol Sci | 2022 | 36555547 | PubTator, text mining | PubMed |
| Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer. | Cancers (Basel) | 2022 | 36551617 | PubTator, text mining | PubMed |
| Hub Genes in Non-Small Cell Lung Cancer Regulatory Networks. | Biomolecules | 2022 | 36551208 | PubTator, text mining | PubMed |
| Investigation of hub genes and immune infiltration in androgenetic alopecia using bioinformatics analysis. | Ann Transl Med | 2022 | 36544676 | PubTator, text mining | PubMed |
| Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis. | Ann Transl Med | 2022 | 36544675 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=51